Tanaka H, Horie Y, Idobe Y, Murawaki Y, Suou T, Kawasaki H
The Second Department of Internal Medicine, Faculty of Medicine, Tottori University, Yonago, Japan.
Hepatogastroenterology. 1998 Sep-Oct;45(23):1777-80.
Portal vein thrombosis as a complication of liver cirrhosis has been reported to be extremely rare in Japan, as compared with European countries. There are few reports discussing the correlation of portal vein thrombosis with refractory ascites. Between January 1994 and December 1995, 20 cases (91%) of 22 patients with liver cirrhosis with ascites admitted to our hospital responded well within 2 months to a combination therapy of diuretics and albumin infusion, and the other two cases (9%) with refractory ascites were associated with portal vein thrombosis. The ascites in the first patient continued for 1 year, despite diuretics and albumin infusion therapy, and portal vein thrombosis was confirmed by autopsy. The ascites in the other patient continued for more than 4 months, and portal vein thrombosis was detected by ultrasound. Portal vein thrombosis was not found in the other 20 cirrhotic patients with ascites. These two cases suggest that portal vein thrombosis may be a contributing factor to refractory ascites in patients with decompensated liver cirrhosis.
与欧洲国家相比,门静脉血栓形成作为肝硬化的一种并发症在日本据报道极为罕见。很少有报告讨论门静脉血栓形成与顽固性腹水之间的相关性。1994年1月至1995年12月,我院收治的22例肝硬化腹水患者中有20例(91%)在2个月内对利尿剂和白蛋白输注联合治疗反应良好,另外2例(9%)顽固性腹水患者合并门静脉血栓形成。第一例患者的腹水尽管接受了利尿剂和白蛋白输注治疗仍持续了1年,尸检证实存在门静脉血栓形成。另一例患者的腹水持续了4个多月,超声检查发现门静脉血栓形成。其他20例肝硬化腹水患者未发现门静脉血栓形成。这两例提示门静脉血栓形成可能是失代偿期肝硬化患者顽固性腹水的一个促成因素。